Table 1.
Type of autoantibodies | Myositis-specific antibodies (MSA) | Myositis-associated antibodies (MAA) | Other autoantibodies often found in myositis |
---|---|---|---|
Autoantibody specificities | Classic MSA: Jo-1, PL-7, PL-12, EJ, OJ, Mi-2, SRP New antibodies that can be considered MSA: KS, TIF1γ/α, TIF1β, MJ/NXP-2, MDA5/CADM-140, SAE |
PM-Scl, Ku, U1RNP, U1/U2RNP, U3RNP | Ro52, Ro60, Su/Ago2 |
Association with SARD | PM/DM, PM/DM-overlap syndrome | PM/DM, PM/DM-overlap syndrome, SSc, SLE | Various SARD |
Detection in non-PM/DM | Uncommon (anti-ARS can be in overlap syndrome and idiopathic ILD) | Not uncommon | Often |
Association with myopathy when found in non-PM/DM | Yes | Yes | No or not established |
Prevalence In general population [20] | Almost none | PM-Scl, Ku, U1/U2RNP—almost none; U1RNP, ~0.1 % | Relatively common (0.5–1 %) |
SARD systemic autoimmune rheumatic diseases, PM polymyositis, DM dermatomyositis, SSc scleroderma, systemic sclerosis, SLE systemic lupus erythematosus, ILD interstitial lung disease